GENE ONLINE|News &
Opinion
Blog

In-depth
Addressing The Global Need for Biosimilars: Current Trends, Expectations and Real World Experiences
2021-08-26
The Defining Role of Metabolism in Human Health and Disease
2021-08-12
New IO Targets and Resistance Mechanisms of Immune Checkpoint-Based Therapies
2021-06-10
The Maturation of Blood-Based Diagnostics to Nip Cancers in the Bud: An Interview with Dr. Jimmy Lin
2021-06-02
Precision Oncology: Overview of Diagnostic Technologies
2021-05-25
A Glance at Gene Therapy Advances in Cancer
2021-05-16
ASGCT21 Highlights: Present Trends and Future Directions of Gene and Cell Therapies in Immuno-Oncology
2021-05-14
Homology Medicines Presents Proof-of-Concept Data for New Antibody Gene Transfer Platform
2021-05-12
The Game Changer: New CRISPR Tool Can Turn On/Off Genes
2021-05-03
CRISPR Gene Editing Could Lead to Possible Detrimental Chromosomal Rearrangement
2021-04-25
Embracing Artificial Intelligence and Machine Learning in Cancer Research and Care
2021-04-18
The Transformative Potential of Gene Therapies for Hemophilia
2021-04-08
CAR-M Therapy – Trojan Horse for Solid Cancer Treatment?
2021-04-05
A Novel Antibody Therapy to Rescue Congenital Teeth Defects
2021-04-04
A Brief Sketch of Gene Therapy Vectors and Delivery Methods
2021-04-03
1 2 3 6
LATEST
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Shaping the Future of the Beauty Industry: Can Skin Microbiome Products Succeed Cosmetics?
2021-10-25
Sanofi, Regeneron’s Dupixent Shines in Phase 3 Trial for Prurigo Nodularis
2021-10-25
ReCode Therapeutics Raises $80 Million in Series B to Advance Gene Therapy & LNP Delivery Platform
2021-10-23
Intellia’s CRISPR Drug Claims FDA Orphan Drug Designation to Treat ATTR Amyloidosis
2021-10-22
Sio Gene Therapies Touts Positive Safety and Biomarker Data for GM1 Gangliosidosis Candidate
2021-10-22
Daiichi Sankyo to Launch mRNA Covid-19 Vaccine in 2022, Shionogi Presents Clinical Results of Covid-19 Oral Drug
2021-10-22
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!